Genomic medicine will occur when research becomes translated into clinical and reduced to practice. Years ago Eric Green, the Director of the National Human Genome Research Institute (and one of the two organizers of the Advances in Genome Biology and Technology conference) would often talk about the need to make […]
Many times the fun of AGBT is the advances in genome technology If you have attended Advances in Genome Biology and Technology in the past, sometimes there is amazing technology presented in a plenary session. Who can forget Stephen Turner’s electrifying talk in 2009’s meeting, complete with fireworks on the […]
David Haussler (UC Santa Cruz): “Every clinician should be able to compare their genome to others.” Here at the first plenary session at the Advances in Genome Biology and Technology 2016, there is a mix of the strange and the familiar. Strange, in that we are not in Marco Island […]
For long-time readers of this blog (and come to think of it, this blog started as a hobby in 2013 so take the term ‘long-time’ with a grain of salt) I want to thank you for finding something valuable here, and for the encouraging feedback I’ve received again and again. […]
“We are lucky to live in this era, before and after NGS; once technology hits (the clinical lab), it is here to stay.” (Panelist at QIAGEN reception, November 4 2015) A week and a half ago, it was the International Congress of Genomics 10 in Shenzhen, China and the BGISEQ-500; […]
The International Congress of Genomics 10 is a conference held annually in Shenzhen, China where BGI is headquartered. Largely attended by life science researchers in China, the invited speakers will have a natural connection to the genetics and genomics community in China, in particular Huanming Yuan. And over the past […]
With my recent transition to the clinical market segment with SeraCare, their major conference for the year is the American Association for Clinical Chemistry. With some 20,000 attendees, and several hundred vendors filling the Atlanta Convention Center, there were a number of interesting real-time instruments shown. I’ll start with the […]
This post is about Seracare’s new direction for Precision Medicine (in particular Precision Oncology), and the launch of a new product the Seraseq Solid Tumor Mutation Mix-I (AF20). But I’ll start first with a story from my days at Illumina. It was ten years ago this week that I last […]
Theral Timpson produces a weekly podcast at Mendelspod.com, and in his latest edition he interviews me about Google X Life Sciences (I wrote about them before here), long-read sequencing (in particular Pacific Biosciences) which then I’m able to discuss the value of complete human diploid sequencing, and my involvement with […]
In the closing session of the Advances in Genome Biology and Technology meeting recently concluded in Marco Island, Florida, the main organizers Dr. Eric Green (National Human Genome Research Institute Director, Bethesda MD) and Dr. Elaine Mardis (Co-director with Rick Wilson of the Genome Institute of Washington University, St. Louis […]
After writing up ‘Marketing Precision Medicine’ it turned out that I spent so much time in giving the background and context, that I only was able to mention briefly the marketing challenge that the Precision Medicine Initiative brings. So here is Part 2, getting deeper into the Marketing challenge of […]
Right about one calendar year ago I was asked to start writing for a new blog for the Genetic Analysis division of Thermo Fisher Scientific. Called ‘Behind the Bench’, it took a few months to get off the ground, and started posting right at the end of May 2014. A […]
